CroiValve

Is there a better way to treat patients with severe+ tricuspid regurgitation? We are excited to announce the first US patient treated with the DUO™ System as part of the TANDEM II Early Feasibility Study. The DUO™ System is a novel transcatheter valve that works in tandem with the native tricuspid valve to restore valve function while preserving the native valve apparatus. "The DUO™ System offers a unique benefit for patients suffering from TR as the device is designed to treat a broad patient population. The procedure is straightforward, leveraging standard interventional techniques and has the potential to accelerate transcatheter tricuspid therapy adoption by more physicians due to the system’s simplicity and scalability." Vinod Thourani Pradeep Yadav https://lnkd.in/gK9PfZg5  #CroiValve #DUO System #Tricuspid Regurgitation Learn more about the DUO System: https://croivalve.com Caution: The DUO System is an investigational device and not for sale in any geography.

CroíValve raises $16 Million in Series B financing to fund the TANDEM II US Early Feasibility Study of the DUO System for patients with severe or greater symptomatic tricuspid regurgitation. https://lnkd.in/gr9-6umF The DUO System is a novel transcatheter heart valve that works in tandem with the native tricuspid valve to restore valve function while leaving the patient’s right heart and native valve apparatus untouched through an innovative anchoring mechanism. Designed to treat a broad patient population, the DUO System accommodates the heterogeneity of patient anatomies while avoiding contact with critical structures in the right heart. #CroiValve#DUO System Learn more about the DUO System: https://croivalve.com CroíValve is a clinical stage medical device company focused the development of a novel transcatheter device for the treatment of tricuspid regurgitation, with R&D & Operations activities based in Ireland and Clinical & Regulatory based in the U.S. Caution: The DUO System is an investigational device and not for sale in any geography.

The management of significant TR in patients with existing pacemaker or defibrillator leads can be challenging. We are excited to announce the first implantation of the CroíValve DUO Coaptation Valve System in a patient with massive tricuspid regurgitation and an implanted pacemaker lead. The implant was safe and resulted in a reduction in regurgitation, right heart reverse remodeling, and associated improvements in quality of life. The DUO System may offer advantages over other current transcatheter approaches. #CroíValve #DUO System Read the article published in Structural Heart. https://lnkd.in/gv-U29x5 Learn more about the DUO System: https://croivalve.com Caution: The DUO System is an investigational device and not for sale in any geography.

We are excited to announce positive six-month outcomes from our TANDEM I trial, presented by Professor @Wojtek Wojakowski at New York Valves 2024. Results demonstrated significant TR reduction, as well as markedly improved functional and Quality of Life outcomes. These findings represent a promising advancement in the treatment of TR with the DUO system. Read more in our latest press release: https://lnkd.in/eabknsx2

CroíValve are growing our team, we have a vacancy for a Senior Quality Engineer in you're interested in joining our team contact us! https://lnkd.in/gZp7yJ9N

Great article about CroíValve’s investigational Duo tricuspid coaptation valve system https://lnkd.in/drAhEfVh

CroiValve have an opening for an R&D Program Manager in our team, this role is a hybrid role, where the candidate can work predominantly from home, with occasional site visits required to meet up with the team. If you're interested get in touch

We have a vacancy in our team for an R&D FEA/Test Engineer. If you are up for the challenge of joining a great team who are developing a novel solution for Tricuspid Regurgitation, get in touch

CroiValve are looking for a Senior Regulatory Affairs Specialist to join are team. This position can be fully remote within 2 hrs of GMT. If you're interested get in touch

We have two openings in our Clinical Team, Clinical Trial Program Manager and Senior Field Clinical Specialist. If you are up for the challenge of joining a great team who are developing a novel solution for Tricuspid Regurgitation, get in touch Clinical Trial Program Manager https://lnkd.in/e-SSa2cs Senior Field Clinical Specialist https://lnkd.in/egxf5qFd